|
注册号: Registration number: |
ChiCTR2500095779 |
|
最近更新日期: Date of Last Refreshed on: |
2025-01-13 15:30:13 |
|
注册时间: Date of Registration: |
2025-01-13 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
不同聚组间歇对血流限制高强度抗阻练习下肢肌肉力量与爆发力的影响研究 |
|
Public title: |
Effects of Combined Interval Blood Flow Restriction with High-Intensity Resistance Training on Lower Limb Muscle Strength and Power |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
不同聚组间歇结合血流限制高强度抗阻练习对下肢肌肉力量与爆发力的急性影响 |
|
Scientific title: |
Acute effects of Combined Interval Blood Flow Restriction with High-Intensity Resistance Training on Lower Limb Muscle Strength and Power |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
郑占飞 |
研究负责人: |
郑占飞 |
|
Applicant: |
Zhanfei Zheng |
Study leader: |
Zhanfei Zheng |
|
申请注册联系人电话: Applicant telephone: |
+86 188 1093 7441 |
研究负责人电话:
Study leader's |
+86 188 1093 7441 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
zhanfei1209@163.com |
研究负责人电子邮件: Study leader's E-mail: |
zhanfei1209@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
温州医科大学 |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
|
|
申请注册联系人通讯地址: |
浙江省温州市瓯海区茶山高教园区温州医科大学 |
研究负责人通讯地址: |
浙江省温州市瓯海区茶山高教园区温州医科大学 |
|
Applicant address: |
Wenzhou Medical University, Chashan Higher Education Park, Ouhai District, Wenzhou City, Zhejiang Province, China |
Study leader's address: |
Wenzhou Medical University, Chashan Higher Education Park, Ouhai District, Wenzhou City, Zhejiang Province, China |
|
申请注册联系人邮政编码: Applicant postcode: |
325035 |
研究负责人邮政编码: Study leader's postcode: |
325035 |
|
申请人所在单位: |
温州医科大学 |
||
|
Applicant's institution: |
Wenzhou Medical University |
||
|
研究负责人所在单位: |
温州医科大学 |
||
|
Affiliation of the Leader: |
Wenzhou Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2024033; 2024077 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
温州医科大学伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Wenzhou Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-09-02 00:00:00 | ||
|
伦理委员会联系人: |
金博闻 |
||
|
Contact Name of the ethic committee: |
Bowen Jin |
||
|
伦理委员会联系地址: |
浙江省温州市瓯海区茶山高教园区温州医科大学 |
||
|
Contact Address of the ethic committee: |
Wenzhou Medical University, Chashan Higher Education Park, Ouhai District, Wenzhou City, Zhejiang Province, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 138 5884 8829 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
温州医科大学 |
||||||||||||||||||||||
|
Primary sponsor: |
Wenzhou Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
浙江省温州市瓯海区茶山高教园区温州医科大学 |
||||||||||||||||||||||
|
Primary sponsor's address: |
Wenzhou Medical University, Chashan Higher Education Park, Ouhai District, Wenzhou City, Zhejiang Province, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
无 |
||||||||||||||||||||||
|
Source(s) of funding: |
N/A |
||||||||||||||||||||||
|
研究疾病: |
无 |
||||||||||||||||||||||
|
Target disease: |
N/A |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机交叉对照 |
||||||||||||||||||||||
|
Study design: |
Cross-over |
||||||||||||||||||||||
|
研究目的: |
探究不同聚组间歇对血流限制高强度抗阻练习下肢肌肉力量与爆发力的急性影响 |
||||||||||||||||||||||
|
Objectives of Study: |
Exploring the Acute Effects of Different Cluster set on Lower Limb Muscle Strength and Power During Blood Flow Restriction High-Intensity Resistance Training |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1.伤病或医疗状况 存在任何可能影响参与抗阻训练的急性或慢性下肢伤病。 被诊断为肌肉骨骼系统疾病,包括关节不稳定或慢性疼痛,影响下肢功能的情况。 2.神经或心血管疾病 存在影响运动控制或肌肉表现的神经系统疾病。 有心血管或代谢疾病史,可能不适合进行高强度运动或血流限制训练。 3.训练或活动限制 当前参与其他可能影响本研究结果的冲突性训练项目。 无法完成研究协议中要求的标准深蹲技术。 4.使用增强类物质 过去12个月内使用过性能增强药物或补剂(如合成代谢类固醇)。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1.Injury or Medical Conditions Presence of any acute or chronic injuries in the lower limbs that could interfere with participation in resistance training. Diagnosis of musculoskeletal disorders, including joint instability or chronic pain affecting lower limb function. 2.Neurological or Cardiovascular Disorders Any neurological conditions affecting motor control or muscle performance. History of cardiovascular or metabolic diseases that contraindicate high-intensity exercise or blood flow restriction protocols. 3.Training or Activity Limitations Current participation in a conflicting training program that may influence the outcomes of this study. Inability to perform proper squat techniques as required for the study protocol. 4.Use of Enhancing Substances Use of performance-enhancing drugs or supplements (e.g., anabolic steroids) in the past 12 months. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-09-03 00:00:00至 To 2025-01-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-09-03 00:00:00 至 To 2025-01-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男性 |
Gender: |
Male |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
本研究采用随机交叉设计,随机化序列由研究团队成员郑占飞通过计算机随机数生成器生成,确保每组受试者的分配具有随机性。15名受试者被随机平均分配至对照组(A组)、干预组B(B组)和干预组C(C组)。A组实验受试者干预完成后进行B组和C组干预,B组受试者干预完成后进行C和A干预,C组受试者干预完成后进行A和B干预,直至15名受试者全部完成A、B和C组干预。各组干预间设置了72小时的洗脱期,以避免前次干预对下一次干预的潜在影响。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The study employs a randomized crossover design, with the randomization sequence generated by the research team member Zheng Zhanfei using a computer random number generator to ensure the random allocation of participants to each group. Fifteen participants are randomly and evenly assigned to the control group (Group A), intervention group B (Group B), and intervention group C (Group C). After completing the intervention in Group A, participants will proceed with interventions in Groups B and C; after completing the intervention in Group B, participants will proceed with interventions in Groups C and A; and after completing the intervention in Group C, participants will proceed with interventions in Groups A and B, until all fifteen participants have completed all three interventions (A, B, and C). A 72-hour washout period is set between interventions to avoid any potential carryover effects from the previous intervention to the subsequent one. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
本研究采用单盲设计,具体施盲对象如下: 研究操作者:负责实施干预的研究人员对受试者的具体干预顺序保持盲态。 数据分析人员:负责数据分析的人员对受试者的干预分组及顺序信息保持盲态,贯穿整个研究过程。 |
|
Blinding: |
This study employed a single-blind design. The blinding was implemented as follows: Study Operators: Researchers responsible for administering the interventions were blinded to the specific intervention sequences of participants. Data Analysts: Personnel responsible for data analysis were blinded to the intervention groups and sequences throughout the study. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
公开日期:试验完成后6个月内 共享方式:向研究者联系索取,联系方式:zhanfei1209@163.com |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Public disclosure date: Within 6 months after trial completion Sharing method: Available upon request by contacting the researcher at: zhanfei1209@163.com |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
无 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
None |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |